glp-1 drugs and parkinson's disease drug shows little benefit for people with | UCL News An update on drug repurposing

Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials

List prices for branded GLP-1 medications can range from several hundred to over $1,000 per month without insurance

3 If initial therapy with metformin and lifestyle efforts are not adequate to achieve individualized glycemic targets, the guidelines recommend that patients should progress to dual therapy by adding either another oral agent, basal insulin, or an injectable GLP-1 receptor agonist

TZD, thiazolidinedione

the question is which fits your lifestyle and comfort level